Physician profile
Jody Beth Spain
NPI 1427364744
$1,630.48
in general payments reported to CMS, 2019-2025
25 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $409 · 2022: $149 · 2023: $207 · 2024: $565 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $225.55 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $214.10 | 2024-2025 | Myfembree, Gemtesa |
| Organon LLC | $171.78 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $118.76 | 2021-2025 | Slynd |
| Amgen INC. | $114.75 | 2021-2025 | Evenity, Prolia, Prolia |
| Organogenesis INC. | $80.83 | 2024 | |
| Eisai INC. | $80.72 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $64.81 | 2021-2023 | Belsomra |
| Novo Nordisk INC | $63.69 | 2024-2025 | Wegovy |
| Astellas Pharma US INC | $54.69 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $52.45 | 2023-2024 | Phexxi |
| Myovant Sciences INC. | $48.15 | 2021 | |
| Janssen Biotech, INC. | $44.74 | 2024 | Tremfya |
| Dexcom, INC. | $39.95 | 2025 | Dexcom G6 Transmitter |
| Galderma Laboratories, L.P. | $36.69 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $34.33 | 2024-2025 | Tymlos |
| Avanos Medical | $32.77 | 2022-2024 | On-Q* Pump and Accessories |
| Idorsia Pharmaceuticals US INC | $29.11 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $21.02 | 2022 | |
| Axonics, INC. | $19.81 | 2023 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $18.49 | 2025 | |
| Mayne Pharma Commercial LLC | $17.97 | 2025 | |
| Lilly USA, LLC | $17.48 | 2022 | |
| Lsi Solutions INC | $15.54 | 2024 | Fornisee |
| Therapeuticsmd, INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Spain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.